Assignee
OMEROS CORP
US77 patents
Top patents by PatentIndex Score
US6645168B2Nov 11, 2003
Arthroscopic irrigation solution and method for inhibition of pain and inflammation
OMEROS CORP78 citations99
US6420432B2Jul 16, 2002
Surgical irrigation solution and method for inhibition of pain and inflammation
OMEROS CORP83 citations99
US6740100B2May 25, 2004
Tendon repair using adhesive
OMEROS CORP124 citations98
US7973068B2Jul 5, 2011
Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
OMEROS CORP71 citations97
US7067144B2Jun 27, 2006
Compositions and methods for systemic inhibition of cartilage degradation
OMEROS CORP100 citations97
US7919094B2Apr 5, 2011
Methods for treating conditions associated with MASP-2 dependent complement activation
OMEROS CORP86 citations95
US6492332B1Dec 10, 2002
Irrigation solution and methods for inhibition of tumor cell adhesion, pain and inflammation
OMEROS CORP126 citations95
US9644035B2May 9, 2017
Methods for treating conditions associated with MASP-2 dependent complement activation
OMEROS CORP18 citations92
US9399040B2Jul 26, 2016
Ophthalmologic irrigation solutions and method
OMEROS CORP11 citations92
US9278101B2Mar 8, 2016
Ophthalmologic irrigation solutions and method
OMEROS CORP14 citations92
US9066856B2Jun 30, 2015
Stable preservative-free mydriatic and anti-inflammatory solutions for injection
OMEROS CORP15 citations92
US8343970B2Jan 1, 2013
PDE10 inhibitors and related compositions and methods
OMEROS CORP12 citations92
US6413961B1Jul 2, 2002
Irrigation solution and method for inhibition of pain and inflammation
OMEROS CORP51 citations92
US9475885B2Oct 25, 2016
Compositions for inhibiting MASP-2 dependent complement activation
OMEROS CORP15 citations91
US7091181B2Aug 15, 2006
Method of inhibition of pain and inflammation during surgery comprising administration of soluble TNF receptors
OMEROS CORP22 citations90
US7786139B2Aug 31, 2010
PDE10 inhibitors and related compositions and methods
OMEROS CORP16 citations89
US9855246B2Jan 2, 2018
Stable preservative-free mydriatic and anti-inflammatory solutions for injection
OMEROS CORP9 citations84
US9585895B2Mar 7, 2017
Ophthalmologic irrigation solutions and method
OMEROS CORP5 citations84
US9486406B2Nov 8, 2016
Stable preservative-free mydriatic and anti-inflammatory solutions for injection
OMEROS CORP10 citations84
US9434707B2Sep 6, 2016
PDE10 inhibitors and related compositions and methods
OMEROS CORP3 citations83
US8685975B2Apr 1, 2014
PDE10 inhibitors and related compositions and methods
OMEROS CORP8 citations83
US8377930B2Feb 19, 2013
PDE10 inhibitors and related compositions and methods
OMEROS CORP11 citations83
US9220715B2Dec 29, 2015
Treatment of addiction and impulse-control disorders using PDE7 inhibitors
OMEROS CORP5 citations82
US7297348B2Nov 20, 2007
Biodegradable triblock copolymers, synthesis methods therefore, and hydrogels and biomaterials made there from
OMEROS CORP18 citations82
US10059776B2Aug 28, 2018
Methods for treating conditions associated with MASP-2 dependent complement activation
OMEROS CORP2 citations73
US9102643B2Aug 11, 2015
PDE10 inhibitors and related compositions and methods
OMEROS CORP3 citations73
US12030853B2Jul 9, 2024
MASP-2 inhibitors and methods of use
OMEROS CORP4 citations72
US11883493B2Jan 30, 2024
Antibodies specifically binding to MASP-3 for the treatment of various diseases and disorders
OMEROS CORP1 citations72
US11661418B2May 30, 2023
MASP-2 inhibitors and methods of use
OMEROS CORP4 citations72
US11207275B2Dec 28, 2021
Treatment of addiction and impulse-control disorders using PDE7 inhibitors
OMEROS CORP2 citations72
US11027015B2Jun 8, 2021
Antibodies specifically binding to MASP-3 for the treatment of various diseases and disorders
OMEROS CORP1 citations72
US10745274B1Aug 18, 2020
Nucleic acids encoding antibodies specifically binding to MASP-3
OMEROS CORP2 citations72
US10639369B2May 5, 2020
Antibodies specifically binding to MASP-3 for the treatment of various diseases and disorders
OMEROS CORP2 citations72
US11584714B2Feb 21, 2023
MASP-2 inhibitors and methods of use
OMEROS CORP5 citations71
US10870708B2Dec 22, 2020
Methods for inhibiting angiogenesis in a subject in need thereof
OMEROS CORP3 citations71
US9677070B2Jun 13, 2017
Composition and method for diversification of target sequences
OMEROS CORP6 citations71
US11807641B2Nov 7, 2023
MASP-2 inhibitors and methods of use
OMEROS CORP2 citations70
US11628217B2Apr 18, 2023
Highly concentrated low viscosity MASP-2 inhibitory antibody formulations, kits, and methods
OMEROS CORP2 citations70
US11453709B2Sep 27, 2022
Chimeric inhibitor molecules of complement activation
OMEROS CORP1 citations69
US11241420B2Feb 8, 2022
Compositions and methods for prophylaxis and treatment of addictions
OMEROS CORP2 citations69
US10064850B2Sep 4, 2018
Compositions and methods for prophylaxis and treatment of addictions
OMEROS CORP2 citations69
US9493447B2Nov 15, 2016
Optically active PDE10 inhibitor
OMEROS CORP3 citations68
US10292374B2May 21, 2019
G protein coupled receptor 85 and SREB3 knockout mice and uses thereof
OMEROS CORP1 citations67
US11896621B2Feb 13, 2024
Methods for treating and/or preventing graft-versus-host disease and/or diffuse alveolar hemorrhage and/or veno-occlusive disease associated with hematopoietic stem cell transplant
OMEROS CORP0 citations62
US11884742B2Jan 30, 2024
Methods for treating conditions associated with MASP-2 dependent complement activation
OMEROS CORP0 citations62
US11525011B2Dec 13, 2022
Methods of inhibiting MASP-2-dependent complement activation in a subject suffering from catastrophic antiphospholipid syndrome
OMEROS CORP1 citations62
US11013772B2May 25, 2021
Methods for treating and/or preventing graft-versus-host disease and/or diffuse alveolar hemorrhage and/or veno-occlusive disease associated with hematopoietic stem cell transplant
OMEROS CORP0 citations62
US11613589B2Mar 28, 2023
Compositions for inhibiting MASP-2 dependent complement activation
OMEROS CORP0 citations61
US11464785B2Oct 11, 2022
Treatment of addiction and impulse-control disorders using PDE7 inhibitors
OMEROS CORP0 citations61
US12486278B2Dec 2, 2025
MASP-2 inhibitors and methods of use
OMEROS CORP0 citations60
Showing the top 50 of 77 patents by PatentIndex Score.